FIGURE 5
(A) Delayed type hypersensitivity test (DTH). One week after the completion of the immunization program, the mice were inoculated in the plantar pad with 50 µl of OVA (0.4 mg/ml). The thickness of the plantar pad was measured at the beginning of the experience as well as 24 and 48 h after inoculation. The bars represent the results of the differences between both measures (ΔA) ± SD and are representative of 2 independent experiments performed. *P < 0.05 and ***P < 0.001 compared with OVA; +++P < 0.001compared with Al(OH)3 at 24 h; ###P < 0.001 and ##P < 0.01 compared with Al(OH)3 at 24 and 48 h, respectively. (B) Representative photographs of plantar pads of the hind legs of mice from the evaluated groups by DHT test at 48 h post OVA injection. The left (L) hind legs were used to challenge with 0.05 ml of OVA (0.4 mg/ml) and the right (R) hind legs were used to inoculate sterile saline solution and served as a control. (a) Intradermal inoculation in the plantar pad, (b) pad thickness measurement with caliber, (c) OVA group, (d) OVA + Al(OH)3 group, (e) OVA + EO group, (f) OVA + Al(OH)3 + EO group

(A) Delayed type hypersensitivity test (DTH). One week after the completion of the immunization program, the mice were inoculated in the plantar pad with 50 µl of OVA (0.4 mg/ml). The thickness of the plantar pad was measured at the beginning of the experience as well as 24 and 48 h after inoculation. The bars represent the results of the differences between both measures (ΔA) ± SD and are representative of 2 independent experiments performed. *P < 0.05 and ***P < 0.001 compared with OVA; +++P < 0.001compared with Al(OH)3 at 24 h; ###P < 0.001 and ##P < 0.01 compared with Al(OH)3 at 24 and 48 h, respectively. (B) Representative photographs of plantar pads of the hind legs of mice from the evaluated groups by DHT test at 48 h post OVA injection. The left (L) hind legs were used to challenge with 0.05 ml of OVA (0.4 mg/ml) and the right (R) hind legs were used to inoculate sterile saline solution and served as a control. (a) Intradermal inoculation in the plantar pad, (b) pad thickness measurement with caliber, (c) OVA group, (d) OVA + Al(OH)3 group, (e) OVA + EO group, (f) OVA + Al(OH)3 + EO group

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close